This observation seems firm since it was derived from the study of 165 patients, therefore, it is tempting to suggest that positive chaperonotherapy may be a promising experimental approach, for example in animal models, by testing FABP4 as an anti-tumor agent in hepatocellular carcinoma. The gene discussed is FABP4; the disease is neoplasm.